Related party transactions |
| Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken. |
| Sr No. | Details of the party (listed entity /subsidiary) entering into the transaction | Details of the counterparty | Type of related party transaction | Details of other related party transaction | Value of the related party transaction as approved by the audit committee | Remarks on approval by audit committee | Value of transaction during the reporting period | In case monies are due to either party as a result of the transaction | In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments | Details of the loans, inter-corporate deposits, advances or investments | Notes |
| Name | PAN | Name | PAN | Relationship of the counterparty with the listed entity or its subsidiary | Opening balance | Closing balance | Nature of indebtedness (loan/ issuance of debt/ any other etc.) | Details of other indebtedness | Cost | Tenure | Nature (loan/ advance/ intercorporate deposit/ investment ) | Interest Rate (%) | Tenure | Secured/ unsecured | Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage) |
| 1 | Panacea Biotec Limited | AAACP5335J | Adveta Power Private Limited | AAJCA6454G | Joint Venture | Any other transaction | Rental Income | 0.09 | As approved by Board | 0.05 | 0.55 | 0.61 | | | | | | | | | | Textual Information(1) |
| 2 | Panacea Biotec Limited | AAACP5335J | Adveta Power Private Limited | AAJCA6454G | Joint Venture | Investment | | | As approved by Board | 0 | 0.9 | 0.9 | | | | | | | | | | Textual Information(2) |
| 3 | Panacea Biotec Pharma Limited | AAKCP4431B | Adveta Power Private Limited | AAJCA6454G | Enterprises over which Person(s) (having control or significant influence over the Company / Key Management Personnel(s), along with their relatives) are able to exercise significant influence | Any other transaction | Interest accrued on loan given | | As approved by Board | 0.02 | 0.04 | 0.02 | | | | | | | | | | Textual Information(3) |
| 4 | Panacea Biotec Pharma Limited | AAKCP4431B | Adveta Power Private Limited | AAJCA6454G | Enterprises over which Person(s) (having control or significant influence over the Company / Key Management Personnel(s), along with their relatives) are able to exercise significant influence | Loan | | 0.5 | As approved by Board | 0.05 | 0.5 | 0.55 | | | | | | | | | | Textual Information(4) |
| 5 | Panacea Biotec Pharma Limited | AAKCP4431B | Panacea Biotec Germany Gmbh | ZZZZZ9999Z | Enterprises over which Person(s) (having control or significant influence over the Company / Key Management Personnel(s), along with their relatives) are able to exercise significant influence | Sale of goods or services | | | As approved by Board | 5.61 | 0 | 0 | | | | | | | | | | Textual Information(5) |
| 6 | Panacea Biotec Limited | AAACP5335J | Dr. Rajesh Jain | AAGPJ1259G | Chairman and Managing Director | Interest paid | | | As approved by Board | 6.77 | 0 | 0 | | | | | | | | | | Textual Information(6) |
| 7 | Panacea Biotec Limited | AAACP5335J | Dr. Rajesh Jain | AAGPJ1259G | Chairman and Managing Director | Loan | | 500 | As approved by Board | 0 | 150 | 150 | | | | | | | | | | Textual Information(7) |
| 8 | Panacea Biotec Limited | AAACP5335J | Dr. Rajesh Jain | AAGPJ1259G | Chairman and Managing Director | Remuneration | | | As approved by Nomination and Remuneration Committee, Board and Shareholders | 4.51 | 0 | 0 | | | | | | | | | | Textual Information(8) |
| 9 | Panacea Biotec Limited | AAACP5335J | Meyten Realtech Private Limited | AAMCM6020B | Wholly owned subsidiary | Any other transaction | Rent income | 0.02 | As approved by Board | 0.01 | 0 | 0 | | | | | | | | | | Textual Information(9) |
| 10 | Panacea Biotec Limited | AAACP5335J | Meyten Realtech Private Limited | AAMCM6020B | Wholly owned subsidiary | Any other transaction | Rent paid | 4.99 | As approved by Board | 2.72 | 3.36 | 2.19 | | | | | | | | | | Textual Information(10) |
| 11 | Panacea Biotec Limited | AAACP5335J | Meyten Realtech Private Limited | AAMCM6020B | Wholly owned subsidiary | Investment | | | As approved by Board | 0 | 0.1 | 0.1 | | | | | | | | | | Textual Information(11) |
| 12 | Panacea Biotec Limited | AAACP5335J | Rees Investment Limited | ZZZZZ9999Z | Wholly owned subsidiary (Liquidated on May 23, 2019) | Loan | | | As approved by Board | 0 | 585.16 | 585.16 | | | | | | | | | | Textual Information(12) |
| 13 | Panacea Biotec Limited | AAACP5335J | Rees Investment Limited | ZZZZZ9999Z | Wholly owned subsidiary (Liquidated on May 23, 2019) | Any other transaction | Provision made on loan given | | As approved by Board | 0 | 585.16 | 585.16 | | | | | | | | | | Textual Information(13) |
| 14 | Panacea Biotec Limited | AAACP5335J | Mr. Ankesh Jain | AHFPJ0287Q | Whole-time Director | Remuneration | | | As approved by Nomination and Remuneration Committee, Board and Shareholders | 7.85 | 0 | 0 | | | | | | | | | | Textual Information(14) |
| 15 | Panacea Biotec Limited | AAACP5335J | Mr. Ashwani Jain | ADHPJ9248H | Chief Operating Officer | Remuneration | | | As approved by Board | 1.48 | 0 | 0 | | | | | | | | | | Textual Information(15) |
| 16 | Panacea Biotec Limited | AAACP5335J | Mr. Devender Gupta | AEOPG9556P | CFO and Head Information Technology | Remuneration | | | As approved by Nomination and Remuneration Committee and Board | 3.21 | 0 | 0 | | | | | | | | | | Textual Information(16) |
| 17 | Panacea Biotec Limited | AAACP5335J | Mr. Harshet Jain | AHFPJ0403J | Member of Promoter Group | Remuneration | | | As approved by Board | 1.4 | 0 | 0 | | | | | | | | | | Textual Information(17) |
| 18 | Panacea Biotec Limited | AAACP5335J | Mr. Mukul Gupta | ACGPG4953L | Independent Director | Remuneration | | | As approved by Board | 0.21 | 0 | 0 | | | | | | | | | | Textual Information(18) |
| 19 | Panacea Biotec Limited | AAACP5335J | Mr. Narotam Kumar Juneja | ACJPJ2883P | Non-Executive Non-Independent Director | Remuneration | | | As approved by Board | 0.09 | 0 | 0 | | | | | | | | | | Textual Information(19) |
| 20 | Panacea Biotec Pharma Limited | AAKCP4431B | Mr. Narotam Kumar Juneja | ACJPJ2883P | Whole-time Director | Remuneration | | | As approved by Board and shareholders | 0.8 | 0 | 0 | | | | | | | | | | Textual Information(20) |
| 21 | Panacea Biotec Pharma Limited | AAKCP4431B | Mrs. Manjula Upadhyay | AAIPU0880G | Independent Director | Remuneration | | | As approved by Board | 0.16 | 0 | 0 | | | | | | | | | | Textual Information(21) |
| 22 | Panacea Biotec Pharma Limited | AAKCP4431B | Mr. Taric Jain | AHFPJ0404R | Sr. Software Engineer | Remuneration | | | As approved by Board | 0.8 | 0 | 0 | | | | | | | | | | Textual Information(22) |
| 23 | Panacea Biotec Pharma Limited | AAKCP4431B | Mr. Ankesh Jain | AHFPJ0287Q | Whole-time Director | Remuneration | | | As approved by Board and shareholders | 1.61 | 0 | 0 | | | | | | | | | | Textual Information(23) |
| 24 | Panacea Biotec Limited | AAACP5335J | Mrs. Ambika sharma | AIDPS0587K | Independent Director | Remuneration | | | As approved by Board | 0.18 | 0 | 0 | | | | | | | | | | Textual Information(24) |
| 25 | Panacea Biotec Limited | AAACP5335J | Mrs. Manjula Upadhyay | AAIPU0880G | Independent Director | Remuneration | | | As approved by Board | 0.22 | 0 | 0 | | | | | | | | | | Textual Information(25) |
| 26 | Panacea Biotec Limited | AAACP5335J | Mr. Ankesh Jain | AHFPJ0287Q | Whole-time Director | Remuneration | | | As approved by Board | 0.06 | 0 | 0 | | | | | | | | | | Textual Information(26) |
| 27 | Panacea Biotec Limited | AAACP5335J | Mr. Sandeep Jain | ADJPJ6765H | Joint Managing Director | Remuneration | | | As approved by Nomination and Remuneration Committee, Board and Shareholders | 4.18 | 0 | 0 | | | | | | | | | | Textual Information(27) |
| 28 | Panacea Biotec Limited | AAACP5335J | Mr. Tanish Jain | AHFPJ0406P | Assistant Manager | Remuneration | | | As approved by Board | 0.6 | 0 | 0 | | | | | | | | | | Textual Information(28) |
| 29 | Panacea Biotec Limited | AAACP5335J | Mr. Vinod Goel | AHBPG9784H | Group CFO and Head Legal & CS | Remuneration | | | As approved by Nomination and Remuneration Committee and Board | 4.49 | 0 | 0 | | | | | | | | | | Textual Information(29) |
| 30 | Panacea Biotec Limited | AAACP5335J | MR Lex Corp LLP | ABIFM5765B | Enterprises over which Person(s) (having control or significant influence over the Company / Key Management Personnel(s), along with their relatives) are able to exercise significant influence | Purchase of goods or services | | | As approved by Board | 0.64 | 0.85 | 0.39 | | | | | | | | | | Textual Information(30) |
| 31 | Panacea Biotec Limited | AAACP5335J | Neophar Alipro Limited | AABCN3612P | Enterprises over which Person(s) (having control or significant influence over the Company / Key Management Personnel(s), along with their relatives) are able to exercise significant influence | Any other transaction | Rental Income | 0.16 | As approved by Board | 0.09 | 0 | 0 | | | | | | | | | | Textual Information(31) |
| 32 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec (International) S.A., Switzerland | ZZZZZ9999Z | Wholly owned subsidiary | Any other transaction | Allowance of doubtful loan | | As approved by Board | 0 | 96.79 | 123.48 | | | | | | | | | | Textual Information(32) |
| 33 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec (International) S.A., Switzerland | ZZZZZ9999Z | Wholly owned subsidiary | Loan | | | As approved by Board | 0 | 96.79 | 123.48 | | | | | | | | | | Textual Information(33) |
| 34 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec (International) S.A., Switzerland | ZZZZZ9999Z | Wholly owned subsidiary | Investment | | | As approved by Board | 0 | 34.36 | 34.36 | | | | | | | | | | Textual Information(34) |
| 35 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec (International) S.A., Switzerland | ZZZZZ9999Z | Wholly owned subsidiary | Any other transaction | Provision for impairment of investment | | As approved by Board | 0 | 34.36 | 34.36 | | | | | | | | | | Textual Information(35) |
| 36 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec (International) S.A., Switzerland | ZZZZZ9999Z | Wholly owned subsidiary | Interest received | | | As approved by Board | 7.69 | 26.7 | 7.69 | | | | | | | | | | Textual Information(36) |
| 37 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec (International) S.A., Switzerland | ZZZZZ9999Z | Wholly owned subsidiary | Any other transaction | Provision for impairment of interest income | | As approved by Board | 7.69 | 26.7 | 7.69 | | | | | | | | | | Textual Information(37) |
| 38 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec Germany Gmbh | ZZZZZ9999Z | Fellow subsidiary | Any other transaction | Allowance of doubtful loan | | As approved by Board | 0 | 319.42 | 407.67 | | | | | | | | | | Textual Information(38) |
| 39 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec Germany Gmbh | ZZZZZ9999Z | Fellow subsidiary | Loan | | | As approved by Board | 0 | 319.42 | 407.67 | | | | | | | | | | Textual Information(39) |
| 40 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec Germany Gmbh | ZZZZZ9999Z | Fellow subsidiary | Interest received | | | As approved by Board | 25.39 | 88.25 | 25.39 | | | | | | | | | | Textual Information(40) |
| 41 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec Germany Gmbh | ZZZZZ9999Z | Fellow subsidiary | Any other transaction | Provision for impairment of interest income | | As approved by Board | 25.39 | 88.25 | 25.39 | | | | | | | | | | Textual Information(41) |
| 42 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec Pharma Limited | AAKCP4431B | Wholly owned subsidiary | Any other transaction | Trade payable | | As approved by Board | 5.17 | 147.72 | 142.55 | | | | | | | | | | Textual Information(42) |
| 43 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec Germany Gmbh | ZZZZZ9999Z | Fellow subsidiary | Any other transaction | Trade receivable | | As approved by Board | 0.04 | 1.12 | 1.17 | | | | | | | | | | Textual Information(43) |
| 44 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec Germany Gmbh | ZZZZZ9999Z | Fellow subsidiary | Any other transaction | Trade payable | | As approved by Board | 0.76 | 21.22 | 21.98 | | | | | | | | | | Textual Information(44) |
| 45 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec Pharma Limited | AAKCP4431B | Wholly owned subsidiary | Sale of goods or services | | | As approved by Board | 0.3 | 0 | 0 | | | | | | | | | | Textual Information(45) |
| 46 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec Pharma Limited | AAKCP4431B | Wholly owned subsidiary | Any other transaction | Rent received | | As approved by Board | 13.71 | 0 | 0 | | | | | | | | | | Textual Information(46) |
| 47 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec Pharma Limited | AAKCP4431B | Wholly owned subsidiary | Any other transaction | Interest expense and accrued | | As approved by Board | 53.68 | 96 | 48.31 | | | | | | | | | | Textual Information(47) |
| 48 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec Pharma Limited | AAKCP4431B | Wholly owned subsidiary | Purchase of goods or services | | | As approved by Board | 0.1 | 0 | 0 | | | | | | | | | | Textual Information(48) |
| 49 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec Pharma Limited | AAKCP4431B | Wholly owned subsidiary | Any other transaction | Transfer of accrued retirement benefits upon transfer of employees | | As approved by Board | 0 | 13.28 | 0 | | | | | | | | | | Textual Information(49) |
| 50 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec Pharma Limited | AAKCP4431B | Wholly owned subsidiary | Any other transaction | Reimbursement of expenses | | As approved by Board | 11.78 | 0 | 0 | | | | | | | | | | Textual Information(50) |
| 51 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec Pharma Limited | AAKCP4431B | Wholly owned subsidiary | Any other transaction | Recovery of expenses | | As approved by Board | 11.52 | 0 | 0 | | | | | | | | | | Textual Information(51) |
| 52 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec Pharma Limited | AAKCP4431B | Wholly owned subsidiary | Investment | | | As approved by Board | 0 | 1 | 1 | | | | | | | | | | Textual Information(52) |
| 53 | Panacea Biotec Limited | AAACP5335J | PanEra Biotec Private Limited | AACCP3032C | Associate | Any other transaction | Rental Income | 0.15 | As approved by Board | 0.08 | 0.22 | 0.32 | | | | | | | | | | Textual Information(53) |
| 54 | Panacea Biotec Limited | AAACP5335J | PanEra Biotec Private Limited | AACCP3032C | Associate | Investment | | | As approved by Board | 0 | 4.2 | 4.2 | | | | | | | | | | Textual Information(54) |
| 55 | Panacea Biotec Limited | AAACP5335J | PanEra Biotec Private Limited | AACCP3032C | Associate | Any other transaction | Provision for impairment of investment | | As approved by Board | 0 | 4.2 | 4.2 | | | | | | | | | | Textual Information(55) |
| 56 | Panacea Biotec Pharma Limited | AAKCP4431B | PanEra Biotec Private Limited | AACCP3032C | Enterprises over which Person(s) (having control or significant influence over the Company / Key Management Personnel(s), along with their relatives) are able to exercise significant influence | Any other transaction | Interest income and interest accrued | | As approved by Board | 3.17 | 6.26 | 2.85 | | | | | | | | | | Textual Information(56) |
| 57 | Panacea Biotec Pharma Limited | AAKCP4431B | PanEra Biotec Private Limited | AACCP3032C | Enterprises over which Person(s) (having control or significant influence over the Company / Key Management Personnel(s), along with their relatives) are able to exercise significant influence | Any other transaction | Provision made on interest earned / accrued | | As approved by Board | 3.17 | 6.26 | 2.85 | | | | | | | | | | Textual Information(57) |
| 58 | Panacea Biotec Limited | AAACP5335J | Panacea Biotec Pharma Limited | AAKCP4431B | Wholly owned subsidiary | Loan | | 1800 | As approved by Board | 346.5 | 1038.73 | 1385.23 | | | | | | | | | | Textual Information(58) |
| 59 | Panacea Biotec Pharma Limited | AAKCP4431B | PanEra Biotec Private Limited | AACCP3032C | Enterprises over which Person(s) (having control or significant influence over the Company / Key Management Personnel(s), along with their relatives) are able to exercise significant influence | Loan | | 95 | As approved by Board | 0 | 63.9 | 70.16 | | | | | | | | | | Textual Information(59) |
| 60 | Panacea Biotec Pharma Limited | AAKCP4431B | PanEra Biotec Private Limited | AACCP3032C | Enterprises over which Person(s) (having control or significant influence over the Company / Key Management Personnel(s), along with their relatives) are able to exercise significant influence | Any other transaction | Provision made on loan given | | As approved by Board | 0 | 63.9 | 70.16 | | | | | | | | | | Textual Information(60) |
| Total value of transaction during the reporting period | | | | | | | | | | 563.95 | | | | | | | | | | | | |